Mechanism of Action: Vitamin K Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Vitamin K Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-005 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-006 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-007 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-008 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-001 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-009 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | JANTOVEN | warfarin sodium | TABLET;ORAL | 040416-002 | Oct 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
